-
Fragment-sized thiazoles in fragment-based drug discovery campaigns : friend or foe?Proj, Matic ...Thiazoles exhibit a wide range of biological activities and therefore represent useful and attractive building blocks. To evaluate their usefulness and pinpoint their liabilities in fragment ... screening campaigns, we assembled a focused library of 49 fragment-sized thiazoles and thiadiazoles with various substituents, namely amines, bromides, carboxylic acids, and nitriles. The library was profiled in a cascade of biochemical inhibition assays, redox activity, thiol reactivity, and stability assays. Our study indicates that when thiazole derivatives are identified as screening hits, their reactivity should be carefully addressed and correlated with specific on-target engagement. Importantly, nonspecific inhibition should be excluded using experimental approaches and in silico predictions. To help with validation of hits identified in fragment screening campaigns, we can apply our high-throughput profiling workflow to focus on the most tractable compounds with a clear mechanism of action.Vir: ACS Medicinal Chemistry Letters. - ISSN 1948-5875 (Vol. 13, iss. 12, 2022, str. 1905–1910)Vrsta gradiva - članek, sestavni del ; neleposlovje za odrasleLeto - 2022Jezik - angleškiCOBISS.SI-ID - 130706947
Avtor
Proj, Matic |
Hrast, Martina |
Knez, Damijan, farmacevt |
Bozovičar, Krištof |
Grabrijan, Katarina |
Meden, Anže |
Gobec, Stanislav, 1970- |
Frlan, Rok
Teme
Tiazoli |
Farmacevtska kemija |
thiazoles |
hit profiling |
promiscuous compounds |
frequent hitters |
privileged scaffolds |
fragments |
hit profiliranje |
promiskuitetne spojine |
pogosti napadalci |
privilegirani odri |
fragmenti
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Avtor | Proj, Matic ... |
Naslov | Fragment-sized thiazoles in fragment-based drug discovery campaigns : friend or foe? |
Datum objave | |
COBISS.SI-ID | 130706947 |
Verzija objave v repozitoriju | Založnikova različica |
Licenca objave v repozitoriju | Creative Commons Priznanje avtorstva 4.0 Mednarodna |
Embargo | Takojšnja javna objava |
Projekti, iz katerih je bila financirana objava
Naziv | Akronim | Številka projekta | Financer |
---|---|---|---|
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin | P1-0208-2022 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
|
Razvoj protibakteriskih učinkovin z delovanjem na validirane tarče v biosintezi peptidoglikana | J1-2484-2020 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
Datoteke, ki spadajo k objavi
Povezava |
---|
![]() |
![]() |
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Proj, Matic | 52376 |
Hrast, Martina | 32036 |
Knez, Damijan, farmacevt | 36438 |
Bozovičar, Krištof | 53738 |
Grabrijan, Katarina | 50814 |
Meden, Anže | 53584 |
Gobec, Stanislav, 1970- | 15284 |
Frlan, Rok | 26512 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.